| Nov. 17 | Study of Hexaxim Compared With Pentaxim Administered With a Monovalent Hepatitis B Vaccine in Healthy Chinese Infants. | Sanofi | Haemophilus Influenzae Type b Immunisation; Hepatitis B Immunisation |
| Nov. 17 | A Study to Evaluate the Safety and Efficacy of Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM) | Bristol-Myers Squibb | Non-obstructive Hypertrophic Cardiomyopathy |
| Nov. 17 | Intravenous Recombinant Human Prourokinase (rhPro-UK) for Acute Ischemic Stroke Within 4.5 to 24 Hours of Onset | Tasly Biopharmaceuticals Co., Ltd. | Acute Ischemic Stroke AIS |
| Nov. 17 | A Study to Evaluate the Efficacy and Safety of BRC-201 in Patients With Acute Uncomplicated Influenza | Boryung Biopharma Co., Ltd. | Influenza |
| Nov. 17 | A Phase Ⅲ Clinical Trial of an Investigative 24-valent Pneumococcal Polysaccharide Conjugate Vaccine | Reinovax Biologics Co., LTD | Pneumococcal Infectious Disease |
| Nov. 16 | The Efficacy and Safety of DLBS1442 in Patients With Primary Dysmenorrhea | Dexa Medica Group | Primary Dysmenorrhea |
| Nov. 16 | A Study to Assess the Effect of Pacibekitug on Major Cardiovascular Events in Patients After a Myocardial Infarction | Novartis Pharmaceuticals | Myocardial Infarction |
| Nov. 16 | A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants With Multiple Sclerosis (MS) | Hoffmann-La Roche | Multiple Sclerosis |
| Nov. 16 | The Efficacy and Safety of DLBS3233 in Adults With Prediabetes | Dexa Medica Group | Prediabetes |
| Nov. 13 | A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia | Hemab ApS | Thrombasthenia |
| Nov. 13 | An Efficacy and Safety Study to Assess an Inhaled, Fixed-dose, Budesonide/Formoterol Fumarate in Participants Aged 4 to Less Than 12 Years of Age With Moderate Persistent Asthma | AstraZeneca | Asthma |
| Nov. 13 | A Multicenter Study Evaluating the Efficacy and Safety of Nivolumab and Ipilimumab in Combination With NP-101 Versus Placebo in Refractory Advanced and Metastatic Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NECs) | Novatek Pharmaceuticals | Gastroenteropancreatic Neuroendocrine Tumors |
| Nov. 13 | RC118 Combined With RC148 as First-Line Treatment for Claudin 18.2-Positive, HER2-Negative Advanced G/GEJ Adenocarcinoma | RemeGen Co., Ltd. | Advanced Gastric or Gastroesophageal Junction Adenocarcinoma |
| Nov. 13 | IIIb Trial for RC28-E Injection in Participants With DME and wAMD | RemeGen Co., Ltd. | Diabetic Macular Edema (DME); wAMD |
| Nov. 12 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise | Novo Nordisk A/S | Diabetes Mellitus, Type 2 |
| Nov. 12 | A Study to Evaluate the Safety and Efficacy (How Well the Study Treatment Works) of ABBV-2294 in Adult Participants With Systemic Sclerosis That Are Currently Receiving Local Standard of Care Treatment, and to Determine the Best Dose of ABBV-2294 to be Evaluated Further. | AbbVie | Systemic Sclerosis |
| Nov. 12 | Effect of S-Ibuprofen Gel on Pain in Acute Soft Tissue Contusions | Aponia Laboratories, Inc. | Acute Pain Due to Trauma |
| Nov. 12 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both | Novo Nordisk A/S | Type 2 Diabetes |
| Nov. 12 | The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or Overweight | Pfizer | Urinary Incontinence, Stress; Overweight and/or Obesity |
| Nov. 12 | A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve Patients | AstraZeneca | Hypercholesterolemia |
| Nov. 12 | [18F]FET PET for Differentiating Tumor Progression vs Treatment-Related Changes in Brain Metastases | Telix Pharmaceuticals (Innovations) Pty Limited | Brain Metastasis; Radiation Necrosis |
| Nov. 12 | A Study in Participants With Relapsed or Refractory Multiple Myeloma for QLS4131 | Qilu Pharmaceutical Co., Ltd. | Relapsed or Refractory Multiple Myeloma |
| Nov. 12 | A Study to Investigate Long-term Safety and Tolerability of Frexalimab in Participants With Multiple Sclerosis | Sanofi | Multiple Sclerosis |
| Nov. 12 | Clinical Trial to Evaluate the Safety and Efficacy of DW4421 in Patients With Erosive Reflux Disease | Daewon Pharmaceutical Co., Ltd. | Erosive Reflux Disease; GERD (Gastroesophageal Reflux Disease) |
| Nov. 12 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both | Novo Nordisk A/S | Type 2 Diabetes; Chronic Kidney Disease |
| Nov. 12 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both | Novo Nordisk A/S | Diabetes Mellitus, Type 2 |
| Nov. 10 | The Efficacy and Safety of Venglustat Compared With Cerezyme in Pediatric Participants 2 to 11 Years of Age With Gaucher Disease Type 3 (GD3) | Sanofi | Gaucher's Disease Type III |
| Nov. 10 | A Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With Obrixtamig | Boehringer Ingelheim | Advanced Cancer |
| Nov. 10 | Efficacy and Safety of Polisorb® MP in the Complex Therapy of Patients With Atopic Dermatitis | Polisorb Joint Stock Company | Atopic Dermatitis |
| Nov. 10 | A Study of Ceftobiprole Compared With Standard Antibiotic Treatment in Children With Staphylococcus Aureus Bacteremia (SAB) Infection, Including Right-sided Heart Infection | ISTx, LLC | Staphylococcus Aureus Bacteremia; Endocarditis, Bacterial |
| Nov. 10 | Continuation Study With Oral MC-1 for Treatment of Patients With PNPO-Deficiency | Medicure | Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency |
| Nov. 9 | A Study to Assess the Safety of Marstacimab and How Well it Works in People With Mild to Moderate Hemophilia A or B Without Inhibitors | Pfizer | Hemophilia A or B |
| Nov. 9 | A Clinical Trial to Evaluate the Efficacy and Safety of Bevemipretide Ophthalmic Topical Solution in Subjects Who Have Dry Age-Related Macular Degeneration (Dry AMD) | Mighty Therapeutics, Inc. | Dry AMD; Age-Related Macular Degeneration (AMD) |
| Nov. 9 | Clinical Trial Evaluating the Efficacy and Safety of Navepegritide and Lonapegsomatropin in Achondroplasia | Ascendis Pharma A/S | Achondroplasia |
| Nov. 9 | A Study of SYS6010 Combined With Enlonstobart in Patients With Previously Systemic Treatment-Naive R/M Nasopharyngeal Carcinoma | CSPC Megalith Biopharmaceutical Co.,Ltd. | Previously Systemic Treatment-Naive Recurrent or Metastatic Nasopharyngeal Carcinoma |
| Nov. 9 | A Study of QLS5132 in Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | Qilu Pharmaceutical Co., Ltd. | Epithelial Ovarian Cancer; Fallopian Tube Cancer |
| Nov. 9 | A Study Comparing Mesutoclax + Azacitidine Versus Venetoclax + Azacitidine in Untreated Acute Myeloid Leukemia (AML) Patients | Beijing InnoCare Pharma Tech Co., Ltd. | Acute Myeloblastic Leukemia |
| Nov. 9 | A Randomized, Controlled, Double-Blind, Multicenter Phase III Clinical Trial to Evaluate the Efficacy and Safety of Enlonstobart, With or Without SYS6010 as Adjuvant Therapy, in Participants With Pathologically Residual Esophageal Squamous Cell Carcinoma Following Complete Surgical Resection | CSPC Megalith Biopharmaceutical Co.,Ltd. | Esophageal Squamous Cell Carcinoma |
| Nov. 6 | An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) | United Therapeutics | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease |
| Nov. 6 | Phase 2 and 3 Placebo Controlled & Long-term Extension Study of Rilzabrutinib in Adults With iCVID to Evaluate Efficacy, Safety, and Tolerability | Sanofi | Immunodeficiency Common Variable |
| Nov. 6 | Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes | Jiangsu HengRui Medicine Co., Ltd. | Type 2 Diabetes |
| Nov. 6 | A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes | AstraZeneca | Obesity; Overweight |
| Nov. 5 | Two Trials to Evaluate TEV-53408 in Participants With Non-Segmental Vitiligo | Teva Branded Pharmaceutical Products R&D LLC | Vitiligo |
| Nov. 5 | A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010) | Merck Sharp & Dohme LLC | Lymphoma, Large B-Cell, Diffuse; Diffuse Large B-Cell Lymphoma |
| Nov. 5 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) | Pfizer | Obesity; Overweight |
| Nov. 5 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity | Novo Nordisk A/S | Hypertension; Obesity |
| Nov. 5 | Pharmacokinetics, Immunogenicity and Safety of Subcutaneous Dupilumab and Berahyaluronidase Alfa (ALT-B4) Coformulation | Sanofi | Dermatitis Atopic |
| Nov. 5 | A Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular Disease | Hoffmann-La Roche | Overweight; Obesity |
| Nov. 4 | A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2) | Pfizer | Obesity; Overweight and/or Obesity |
| Nov. 4 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Bronchiectasis |
| Nov. 4 | Efficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and Gingivitis | Colgate Palmolive | Plaque; Gingivitis |
| Nov. 4 | Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis | Arcutis Biotherapeutics, Inc. | Atopic Dermatitis; Atopic Dermatitis (AD) |
| Nov. 4 | Sintilimab Combined With LCCRT Followed by Capeox Chemotherapy in pMMR/MSS/MSI-L Locally Advanced Rectal Cancer | Innovent Biologics (Suzhou) Co. Ltd. | Locally Advanced Rectal Cancer |
| Nov. 4 | A Study of Efficacy and Safety of FXS6837 in Anti-C5 Treated PNH Patients. | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Paroxysmal Nocturnal Hemoglobinuria |
| Nov. 4 | A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide Versus Placebo in Children and Adolescents With Hypochondroplasia | Ascendis Pharma A/S | Hypochondroplasia |
| Nov. 3 | HMPL-306 in Participants With Postoperative Residual or Recurrent Grade 2 Glioma Harboring IDH1 or IDH2 Mutations | Hutchmed | Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation |
| Nov. 3 | Phase 3 Study of HS-10380 for Acute Schizophrenia in Chinese Adults | Jiangsu Hansoh Pharmaceutical Co., Ltd. | SCHIZOPHRENIA 1 (Disorder) |
| Nov. 3 | A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin | Jiangsu HengRui Medicine Co., Ltd. | Diabetes Mellitus, Type 2 |
| Nov. 3 | rhTPO for Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Procedures. | MIBIO PTE. LTD. | Thrombocytopenia Associated With Chronic Liver Disease |
| Nov. 3 | GFH375 Plus Cetuximab vs Investigator's Choice of Treatment in KRAS G12D-Mutant Refractory Metastatic Colorectal Cancer | Genfleet Therapeutics (Shanghai) Inc. | Colorectal Cancer |
| Nov. 2 | A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease | Enanta Pharmaceuticals, Inc | RSV |
| Nov. 2 | A Clinical Trial of Gocatamig (MK-6070) With Durvalumab in Participants With Small Cell Lung Cancer (MK-6070-004) | Merck Sharp & Dohme LLC | Small Cell Lung Cancer |
| Nov. 2 | Study of CM336+CM313 Combination Therapy in Patients With Relapsed or Refractory Multiple Myeloma | Keymed Biosciences Co.Ltd | Multiple Myeloma (MM) |
| Nov. 2 | A Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older | Guangzhou Patronus Biotech Co., Ltd. | Respiratory Syncytial Virus (RSV); Respiratory Syncytial Virus (RSV) Infection |
| Nov. 2 | A Study to Evaluate Surovatamig Combined With R-CHOP in Participants of 18 to < 80 Years of Age With Previously Untreated Large B-cell Lymphoma With IPI Score 2 to 5 | AstraZeneca | Large B-cell Lymphoma |
| Oct. 30 | A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate Cancer | Janssen Research & Development, LLC | Prostatic Neoplasms |
| Oct. 30 | The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease | Boehringer Ingelheim | Chronic Obstructive Pulmonary Disease |
| Oct. 29 | To Evaluate Safety and Efficacy of Anitocabtagene Autoleucel Versus Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma | Kite, A Gilead Company | Newly Diagnosed Multiple Myeloma |
| Oct. 29 | Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063. | Inmunotek S.L. | Allergic Rhinitis; Allergic Rhinoconjunctivitis |
| Oct. 29 | A Randomized Study of ELVN-001 Versus Investigator-Selected TKI, in CP-CML Previously Treated With One or More TKIs | Enliven Therapeutics | Chronic Myeloid Leukemia (CML); Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive |
| Oct. 29 | A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy | Jade Biosciences, Inc. | IgA Nephropathy (IgAN) |
| Oct. 29 | A Study to Evaluate the Efficacy and Safety of MG-K10 in Adults With Chronic Rhinosinusitis With Nasal Polyps | Shanghai Mabgeek Biotech.Co.Ltd | Chronic Rhinosinusitis With Nasal Polyps |
| Oct. 29 | A Trial Comparing Ramantamig and Daratumumab (Ramantamig-D) Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible | Janssen Research & Development, LLC | Multiple Myeloma |
| Oct. 29 | A Phase II/III Clinical Study of SIM0811 in the Treatment of Acute Ischemic Stroke | Jiangsu Simcere Pharmaceutical Co., Ltd. | Acute Ischemic Stroke AIS |
| Oct. 29 | Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis_MM09-SIT-069. | Inmunotek S.L. | Allergic Rhinitis; Allergic Rhinoconjunctivitis |
| Oct. 29 | HB0025-C-0301: A Study to Investigate HB0025 Combined With Chemotherapy as First-Line Treatment for Advanced or Recurrent MMR-proficient Endometrial Cancer | Shanghai Huaota Biopharmaceutical Co., Ltd. | First-line pMMR Endometrial Cancer |
| Oct. 28 | Study to Evaluate the Efficacy and Safety of Dexketoprofen / Butylscopolamine vs Dexketoprofen in Treatment of Primary Dysmenorrhea | Laboratorios Silanes S.A. de C.V. | Primary Dysmenorrhea |
| Oct. 28 | Linvoseltamab Versus Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone (Dara-Vcd) in Adult Participants With Newly Diagnosed Systemic Light Chain Amyloidosis | Regeneron Pharmaceuticals | Newly Diagnosed Amyloidosis; Amyloidosis Stage I-IIIA |
| Oct. 28 | Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children | Precigen, Inc | Recurrent Respiratory Papillomatosis (RRP); Juvenile-onset Recurrent Respiratory Papillomatosis |
| Oct. 28 | HRS-4642 Combined With Antitumor Agents for the Treatment of Perioperative Pancreatic Cancer | Shanghai Hengrui Pharmaceutical Co., Ltd. | Systemic Treatment-naïve Pancreatic Cancer |
| Oct. 28 | Study to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT) | Ray Therapeutics, Inc. | Retinitis Pigmentosa (RP); Inherited Retinal Diseases |
| Oct. 28 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Obesity; Overweight |
| Oct. 28 | An Open-Label Study to Determine if BHV-1300 is Safe in Adults With Graves' Disease | Biohaven Therapeutics Ltd. | Graves' Disease |
| Oct. 27 | Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With Hypogonadism | Amneal Pharmaceuticals, LLC | Male Hypogonadism |
| Oct. 27 | ASKC202 Plus Limertinib as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | EGFR Activating Mutation; Non-Squamous Non-Small Cell Lung Cancer (NSCLC) |
| Oct. 27 | A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction Patients | Hanmi Pharmaceutical Company Limited | Erectile Dysfunction |
| Oct. 27 | A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant Recipients | Swedish Orphan Biovitrum | C3 Glomerulopathy (C3G), Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN); Recurrent Glomerular Disease After Kidney Transplantation |
| Oct. 27 | A Study to Learn How Effective, Safe, and Tolerable Upadacitinib is for Young Participants With Non-segmental Vitiligo | AbbVie | Non-Segmental Vitiligo |
| Oct. 27 | Orelabrutinib Plus ICP 248 vs Orelabrutinib for Relapsed/Refractory Marginal Zone Lymphoma | Beijing InnoCare Pharma Tech Co., Ltd. | Relapsed/Refractory Marginal Zone Lymphoma (MZL) |
| Oct. 26 | QLC5508 vs. Investigator's Choice Chemotherapy in Advanced Extrapulmonary Neuroendocrine Carcinoma | Qilu Pharmaceutical Co., Ltd. | Extrapulmonary Neuroendocrine Carcinoma |
| Oct. 26 | A Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing Non-squamous Non-small Cell Lung Cancer | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Non Small Cell Lung Cancer |
| Oct. 26 | SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III Study | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Non-squamous Non-small Cell Lung Cancer |
| Oct. 26 | Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes | Regeneron Pharmaceuticals | Overweight or Obesity Without Diabetes |
| Oct. 26 | A Phase III Clinical Study of HRS-6209 Plus Letrozole as First-line Therapy in Patients With Advanced or Metastatic Breast Cancer | Jiangsu HengRui Medicine Co., Ltd. | Breast Cancer |
| Oct. 22 | Study of a Combination SARS-CoV-2 Recombinant Spike and High-Dose Inactivated Influenza Vaccine With Matrix-M Adjuvant in Adult Participants 60 Years of Age and Older | Sanofi | Immunization; Healthy Volunteers |
| Oct. 22 | A Study of a Medicine Called Atirmociclib in Combination With Giredestrant in Adult Participants With ER-positive, HER2-negative Early-stage Breast Cancer | Pfizer | Early Breast Cancer; Estrogen Receptor Positive (ER+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-) |
| Oct. 22 | Combined Metabolic Activator Supplementation in Subjects Diagnosed With Gout | ScandiBio Therapeutics AB | Gout Disease |
| Oct. 22 | A Phase 3b Study of Participant Experience on Povetacicept Administered Via Autoinjector as Compared to Sibeprenlimab Administered Via Prefilled Syringe | Vertex Pharmaceuticals Incorporated | Immunoglobulin A Nephropathy |
| Oct. 22 | Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLC | AVEO Pharmaceuticals, Inc. | Cachexia; Cancer; Cachexia |
| Oct. 22 | A Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar Control on Oral Glucose-Lowering Medications | Hoffmann-La Roche | Type 2 Diabetes Mellitus |